相关实验视频

Updated: Jun 27, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

心血管疾病中的 Nrf2-Keap1:哪个是车子,哪个是马?

Neha Dhyani¹, Changhai Tian², Lie Gao³

¹Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska, United States.

Physiology (Bethesda, Md.)

|April 30, 2024

概括

氧化应激在心血管疾病中很常见. 核因子红色素2相关因子2 (Nrf2) 起着关键作用,其下调会使病情恶化,这表明Nrf2调制是潜在的治疗方法.

科学领域:

心血管科学心血管科学
分子生物学分子生物学
氧化压力研究研究氧化压力研究

背景情况:

诸如心力衰竭,高血压和中风之类的心血管疾病 (CVD) 具有由高水平的循环和组织氧化应激来自反应性氧物质的特征.
核因子红色素2相关因子2 (Nrf2) 是一个重要的转录因子,具有显著的抗氧化和抗炎性质.
人们越来越认识到nrf2在心血管疾病的发病和进展中的作用.

研究的目的:

审查Nrf2在心血管疾病的发展和维持中的多方面的作用.
检查Nrf2下调对心力衰竭,高血压和自主功能障碍等疾病的影响.
探索针对Nrf2通路治疗心血管疾病和自主功能障碍的治疗潜力.

主要方法:

关于Nrf2,氧化应激和心血管疾病现有研究的综合文献综述.
对研究Nrf2调制对心血管和自主功能影响的研究进行分析.
综合证据,将Nrf2活性与疾病发病和治疗策略联系起来.

主要成果:

研究表明,降低Nrf2水平会加剧包括心力衰竭,高血压和自主功能受损在内的疾病.
有证据表明,Nrf2激活对氧化应激引起的心血管损伤具有保护作用.
对Nrf2的下调与各种心血管病理的敏感性和严重性增加有关.

结论:

Nrf2是心血管系统中细胞防御抗氧化应激的关键调节者.
旨在调节Nrf2活性的治疗策略对治疗一系列心血管疾病具有前景.
准Nrf2可能为管理与心血管疾病相关的自主功能障碍提供一种新的方法.

关键词:

Nrf2 没有任何问题.抗氧化蛋白质是一种抗氧化蛋白质.心脏衰竭是因为心脏衰竭.这种高血压,高血压.氧化应激是一种氧化应激.

更多相关视频

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Transducer Mechanism: Nuclear Receptors

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

Regulation of the Unfolded Protein Response

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...